Clinical trial
Medical Therapy of Prostatic Symptoms
NCT00021814 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00021814 |
|---|---|
| Title | Medical Therapy of Prostatic Symptoms |
| Official title | Medical Therapy of Prostatic Symptoms |
| Acronym | MTOPS |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | George Washington University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostatic Hyperplasia, Prostatic Hypertrophy, Benign |
| Intervention type | Drug |
| Interventions | Doxazosin, Finasteride, Doxazosin placebo, Finasteride placebo |
| Enrollment | 3,407 |
| Start date | Dec 1, 1995 |
| Primary completion | Nov 30, 2001 |
| Completion | Nov 30, 2001 |
| First posted | Aug 6, 2001 |
| Last update posted | Sep 28, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: